Get decision support for the best
personalized treatment option

Whatever your diagnosis, our expert network will help you identify your best personalized treatment options—quickly, clearly, and free of charge. ASK Cancer Commons now.

Whatever your diagnosis, our expert network will help you identify your best personalized treatment options—quickly, clearly, and free of charge. ASK Cancer Commons now.

Whatever your diagnosis, our expert network will help you identify your best options quickly, clearly, and free of charge. ASK Cancer Commons now.

Cancer Commons and xCures invite participation from patients who try a new combination therapy with promising early results. Read now.

Cancer Commons and xCures invite participation from patients who try a new combination therapy with promising early results. Read now.

Cancer Commons and xCures invite participation from patients who try a new combination therapy with promising early results. Read now.

Dyanne ski

Sheena advocates for the best possible treatment for her mother's glioblastoma. Read her story.

An early retired globetrotter faces a breast cancer diagnosis. Read her story.

An early retired globetrotter faces a breast cancer diagnosis. Read her story.

Navigating Cancer
Abroad
Row of houses

Founder and melanoma survivor Marty Tenenbaum is dedicated to helping every patient access the knowledge they need. Read Marty's story.

Founder and melanoma survivor Marty Tenenbaum is dedicated to helping every patient access the knowledge they need. Read Marty's story.

Founder and melanoma survivor Marty Tenenbaum is dedicated to helping every patient access the knowledge they need. Read Marty's story.

Born from
necessity
previous arrow
next arrow
Slider

Changing the way the world treats cancer, starting with you.

Cancer Commons is a patient-centric not-for-profit network of patients, physicians, and scientists that help identify the best options for treating an individual’s cancer. Members contribute to and benefit from a uniquely dynamic knowledge base of case histories, treatment insights and rationales, clinical trials, and patient outcomes and experiences.

Each case builds on this collective knowledge, enabling more accurate personalized options for the next community member.  By learning from each and every patient in this way, we can optimize and expand the use of available treatments far more efficiently than clinical trials, and rapidly improve outcomes for patients with advanced cancer.